Therapeutic antibodies
from EU-approved medicines

Currently, we offer 18 different therapeutic monoclonal antibodies from EU licensed drugs for use in R&D, preclinical development, process development, manufacturing & clinical development. Research-relevant quantities of the original drug are available as aliquot or dilution.

Therapeutic molecule
Antigen
Filters Sort results
Drug name
Therapeutic molecule
Antigen
Bevacizumab
VEGF-A
Secukinumab
IL 17A
Ramucirumab
VEGFR2
Daratumumab
CD38
Etanercept
TNF-α
Cetuximab
EGFR
Obinutuzumab
CD20
Trastuzumab
HER2
Adalimumab
TNF-α
Pembrolizumab
PD-1
Rituximab
CD20
Nivolumab
PD-1
Denosumab
RANKL
Infliximab
TNF-α
Tocilizumab
IL-6 R
Golimumab
TNF-α
Ustekinumab
IL-12
Palivizumab
RSV protein F

Showing 1–12 of 18 results